Publications

Scholarly Journals--Published

• Brothers J, Castillo DR, Jeon WJ, Joung B, Yuliya Linhares (2023) Partial Response to Venetoclax and Ruxolitinib Combination in a Case of Refractory T-Prolymphocytic Leukemia. Hematology. 28:1, 2237342, DOI:10.1080/16078454.2023.2237342 (2023) (link)
• Hino C, Lacy C, Brothers J, Cao HL, Mirshahidi H, Park K, Akhtari M. Factors Influencing Physician Discretion to Administer CNS Prophylaxis in Diffuse Large B Cell Lymphoma: A Single Institution Retrospective Study. Clin Lymphoma Myeloma Leuk. 2023 Jul 6;S2152-2650(23)00197-0. DOI: 10.1016/j.clml.2023.06.009. (2023) (link)
• Jeon WJ, Moon JH, Pham B, Joung B, Brothers J. An Exceptional Response to Immune-Checkpoint Inhibitor Therapy in  Undifferentiated Pleomorphic Sarcoma. Front Oncol. 2023; 13: 1198292. DOI: 10.3389/fonc.2023.1198292. (2023) (link)
• Castillo DR, Park D, Jeon WJ, Joung B, Lee J, Yang C, Pham B, Hino C, Chong E, Shields A, Duong T, Kaur S, Park K, Nguyen A, Brothers J, Liu Y, Akhtari M, Zhang K, Cao H. Unveiling the Prognostic Significance of BCL6+/CD10+ Mantle Cell Lymphoma: A Systematic Review and Meta-Analysis. Int J Mol Sci. 2023 Jun 16;24(12):10207. DOI: 10.3390/ijms241210207. (2023) (link)
• Jin Jeon WJ, Nguyen J, Castillo DR, Park K, Brothers J, Nguyen A, Mirshahidi H. Recurrent and Atypical Immune Checkpoint Inhibitor-Induced Pneumonitis. J Oncol Pharm Pract. 2023;29(5):1264-1267. DOI: 10.1177/10781552221150936  (2023) (link)
• Gish RG, Regenstein FG, Flamm SL, Stravitz RT, Brothers, JM. Guidance for Coagulation Management in Patients with Acute or Chronic Liver Failure. Gastroenterology and Hepatology. 2021;17(1 Suppl.) S1-26. (02/2021) (link)
• Brothers JM, Kidwell KM, Brown RK, Henry NL. Incidental radiologic findings at breast cancer diagnosis and likelihood of disease recurrence. Breast Cancer Res Treat. 2016;155(2):395-403. doi:10.1007/s10549-016-3687-1 (09/2020) (link)